<DOC>
	<DOCNO>NCT02671682</DOCNO>
	<brief_summary>This observational study investigate efficacy safety immunoadsorption versus plasmapheresis 60 patient relapse Multiple Sclerosis Clinically isolate syndrome fully recover high dos intravenous corticosteroid .</brief_summary>
	<brief_title>Immunoadsorption vs. Plasmapheresis Escalation Therapy Relapse Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>relapse Multiple Sclerosis Clinically Isolated Syndrome ( without complete remission high dose steroid therapy ) inform consent age â‰¥ 12 year old clinical laboratory sign infection intake Angiotensin Converting Enzyme Inhibitor within 1 week prior first treatment</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Immunoadsorption</keyword>
	<keyword>Plasmapheresis</keyword>
</DOC>